APA (7th ed.) Citation

AH, C., KA, T., K, F., E, H., RF, C., & ME, T. (2015). Desvenlafaxine 50 and 100 mg/d versus placebo for the treatment of major depressive disorder: A phase 4, randomized controlled trial. The Journal of clinical psychiatry, 76(5), 562. https://doi.org/10.4088/JCP.13m08978

Chicago Style (17th ed.) Citation

AH, Clayton, Tourian KA, Focht K, Hwang E, Cheng RF, and Thase ME. "Desvenlafaxine 50 and 100 Mg/d Versus Placebo for the Treatment of Major Depressive Disorder: A Phase 4, Randomized Controlled Trial." The Journal of Clinical Psychiatry 76, no. 5 (2015): 562. https://doi.org/10.4088/JCP.13m08978.

MLA (9th ed.) Citation

AH, Clayton, et al. "Desvenlafaxine 50 and 100 Mg/d Versus Placebo for the Treatment of Major Depressive Disorder: A Phase 4, Randomized Controlled Trial." The Journal of Clinical Psychiatry, vol. 76, no. 5, 2015, p. 562, https://doi.org/10.4088/JCP.13m08978.